Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
In the latest session, Autolus Therapeutics plc ADR (NASDAQ: AUTL) closed at $1.62 down -5.26% from its previous closing price of $1.71. In other words, the price has decreased by -$5.26 from its previous closing price. On the day, 0.61 million shares were traded. AUTL stock price reached its highest trading level at $1.73 during the session, while it also had its lowest trading level at $1.61.
Ratios:
For a deeper understanding of Autolus Therapeutics plc ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.77 and its Current Ratio is at 10.84. In the meantime, Its Debt-to-Equity ratio is 0.70 whereas as Long-Term Debt/Eq ratio is at 0.70.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on November 18, 2024, Upgraded its rating to Buy and sets its target price to $7.60 from $7 previously.
On November 15, 2024, Redburn Atlantic Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $13.
On November 09, 2023, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $10.Deutsche Bank initiated its Buy rating on November 09, 2023, with a $10 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 16 ’24 when Martin Pule bought 698,741 shares for $4.23 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AUTL now has a Market Capitalization of 455080640 and an Enterprise Value of 140334816. For the stock, the TTM Price-to-Sale (P/S) ratio is 42.60 while its Price-to-Book (P/B) ratio in mrq is 0.90. Its current Enterprise Value per Revenue stands at 13.867 whereas that against EBITDA is -0.602.
Stock Price History:
The Beta on a monthly basis for AUTL is 2.05, which has changed by -0.7403846 over the last 52 weeks, in comparison to a change of 0.10063088 over the same period for the S&P500. Over the past 52 weeks, AUTL has reached a high of $6.60, while it has fallen to a 52-week low of $1.56. The 50-Day Moving Average of the stock is -19.08%, while the 200-Day Moving Average is calculated to be -50.17%.
Shares Statistics:
For the past three months, AUTL has traded an average of 1.25M shares per day and 1297390 over the past ten days. A total of 266.12M shares are outstanding, with a floating share count of 240.32M. Insiders hold about 9.70% of the company’s shares, while institutions hold 53.77% stake in the company. Shares short for AUTL as of 1740700800 were 9104667 with a Short Ratio of 7.26, compared to 1738281600 on 9108530. Therefore, it implies a Short% of Shares Outstanding of 9104667 and a Short% of Float of 4.62.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Its stock is currently analyzed by 4.0 different market analysts. The consensus estimate for the next quarter is -$0.26, with high estimates of -$0.19 and low estimates of -$0.3.
Analysts are recommending an EPS of between -$0.66 and -$1.13 for the fiscal current year, implying an average EPS of -$0.92. EPS for the following year is -$0.78, with 7.0 analysts recommending between -$0.41 and -$0.98.
Revenue Estimates
For the next quarter, 5 analysts are estimating revenue of $5.34M. There is a high estimate of $7.19M for the next quarter, whereas the lowest estimate is $3M.
A total of 7 analysts have provided revenue estimates for AUTL’s current fiscal year. The highest revenue estimate was $48.4M, while the lowest revenue estimate was $18.34M, resulting in an average revenue estimate of $31.82M. In the same quarter a year ago, actual revenue was $10.12MBased on 8 analysts’ estimates, the company’s revenue will be $117.66M in the next fiscal year. The high estimate is $260.58M and the low estimate is $50.88M.
